课题基金 / 基金详情

Investigate the potential of Nrf2 modulators as antiviral and anticancer therapeutics

Investigate the potential of Nrf2 modulators as antiviral and anticancer therapeutics
研究 Nrf2 调节剂作为抗病毒和抗癌疗法的潜力
批准号：
342291
负责人：
Lin Rongtuan
金额：
$70.73万
依托单位：
CIUSSS de Centre-Ouest-de-l'Ile-de-Montral-Jewish General
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-03-01 至 2021-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=342291&lang=en
关键词：
Anti-Oxidative Response Anti-Viral Innate Immunity Apoptosis Brusatol Hsv-1 Murine Models Nrf2 Transcription Factor Oncolytic Viruses Sirna Screening Vsv

项目摘要

项目成果

Lin Rongtuan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Virus infection is controlled in large part by the host antiviral immune response. In the past decade, our research, as well as the work of many others, has identified key elements of the immune system that sense and respond to incoming viruses. Recently
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating the role of TRAF7 in regulating antiviral immune response
Investigating the role of TRAF7 in regulating antiviral immune response
Manipulating the immune response to inhibit Ebola virus infection
Manipulating the RIG-I signaling pathway to inhibit influenza virus infection
海外基金